First Trust Advisors’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-22,896
Closed -$41.9K 2597
2024
Q4
$41.9K Buy
+22,896
New +$44.7K ﹤0.01% 2545
2024
Q2
Sell
-39,974
Closed -$150K 2397
2024
Q1
$150K Buy
39,974
+25,366
+174% +$149K ﹤0.01% 2293
2023
Q4
$143K Sell
14,608
-191,663
-93% -$1.57M ﹤0.01% 2317
2023
Q3
$1.72M Buy
206,271
+1,492
+0.7% +$17.1K ﹤0.01% 1745
2023
Q2
$2.72M Buy
+204,779
New +$2.49M ﹤0.01% 1558
2021
Q4
Sell
-114,037
Closed -$2.91M 2577
2021
Q3
$2.91M Sell
114,037
-34,223
-23% -$1.01M ﹤0.01% 1612
2021
Q2
$5.18M Buy
+148,260
New +$4.31M 0.01% 1338
2017
Q1
Sell
-97,396
Closed -$370K 2438
2016
Q4
$370K Buy
+97,396
New +$708K ﹤0.01% 2220
2016
Q3
Sell
-127,934
Closed -$900K 2374
2016
Q2
$900K Buy
+127,934
New +$1.17M ﹤0.01% 1759

Other funds holding PACB